Tompkins Financial’s Repligen RGEN Stock Holding History

Tompkins Financial’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-125	Closed	-$3K	–	466
2016 Q2	$3K	Buy	+125	New	+$3.2K	﹤0.01%	483

Other funds holding RGEN

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Tompkins Financial's RGEN Position: Q3 2016 in Review

Tompkins Financial sold out of Repligen (RGEN) in Q3 2016, closing a stake of 125 shares — an estimated $3K sold.

Tompkins Financial first reported a position in RGEN in Q2 2016 and held it in 1 quarter. The position peaked at $3K in Q2 2016. 182 funds tracked by Wall St. Rank hold RGEN as of Q3 2016.

Tompkins Financial reported no remaining Repligen position as of Q3 2016 after selling out during the quarter.
Tompkins Financial sold 125 Repligen shares in Q3 2016, an estimated $3K.
Tompkins Financial first reported a position in Repligen in Q2 2016 and held it in 1 quarter.
Tompkins Financial's Repligen position peaked at $3K in Q2 2016.
182 funds tracked by Wall St. Rank held Repligen as of Q3 2016.

Based on Tompkins Financial's 13F filing for Q3 2016, filed 13 Oct 2016.